Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.0279 per EA under NDC 70377007813. Its NADAC has been published 143 times since Jan 10, 2024.
FDA first approved this application on Nov 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377007813
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA216436FDA Approved
11/23/2022
TE Code
AB
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 143 times since Jan 10, 2024, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0279 per EA |
|---|---|
| All-time high | $0.0411 (Mar 13, 2024) |
| All-time low | $0.0276 (Aug 19, 2026) |
| 52-week high | $0.0319 |
| 52-week low | $0.0276 |
| Median price | $0.0319 |
| Average price | $0.0331 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 143 |
| Tracking since | Jan 10, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
atorvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Biocon Pharma Inc., is $0.0279 per EA (NDC 70377007813), effective Sep 30, 2026.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 28.7%. It has been tracked across 143 weekly CMS publications since Jan 10, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Jan 10, 2024, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0276 (Aug 19, 2026) to a high of $0.0411 (Mar 13, 2024), with a median of $0.0319 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 70377007813) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.